Abbott Secures US FDA Approval For HPV Screening Solution

Abbott has acquired FDA approval for its molecular human papillomavirus (HPV) screening solution, bringing to the Alinity m family of diagnostic tests a strong cancer screening tool for detecting high-risk HPV infections. According to the US...

Lupin, Zydus Sign Pact To co-market Liver Diseases Drug

Lupin Limited (Lupin) and Zydus Lifesciences Limited (Zydus), a discovery-driven global lifesciences company, announced a licensing and supply agreement to co-market saroglitazar Mg in India for the treatment of non-alcoholic fatty liver...

Vonoprazan gets US FDA Approval for Treatment of Esophagitis

Phathom Pharmaceuticals Inc, an innovative, biopharmaceutical company specializing in gastrointestinal disease treatments

Eppendorf Provides Master cycler X40 to raise Laboratory Quality

Eppendorf, the renowned life science company, specializes in the development and sale of cutting-edge instruments

Bayer and Harvard Institute Extend Research for Cancer Therapies

Bayer and the Broad Institute of MIT and Harvard have recently confirmed the continuation of their collaborative research work for another five years after a successful decade-long partnership

Lupin Launches Diazepam Rectal Gel in US Markets

The unveiling of diazepam rectal gel, available in doses of 10 mg and 20 mg, has been declared by Lupin Limited

Illumina Unveils Liquid Biopsy Assay For Genomic Profiling

Illumina Inc., a global pioneer in DNA sequencing and array-based technologies, has announced the availability of a new version of their distributed liquid biopsy test for genomic profiling. The TruSight Oncology 500 ctDNA v2 (TSO 500 ctDNA v2)...

SPARC Forms Licensing Agreement With JHU & IOCB for Alopecia Drugs

Sun Pharma Advanced Research Company Ltd. (SPARC) announced an agreement with Johns Hopkins University (JHU) and The Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences (IOCB) (Licensors) to exclusively license SCD-153...

US FDA Nods Keytruda Plus Gemcitabine & Cisplatin To treat patients

Merck (MSD) announced that the US Food and Drug Administration (FDA) has approved Keytruda, Merck's anti-PD-1 therapy, in combination with gemcitabine and cisplatin for the treatment of patients with locally advanced unresectable or metastatic...

NRx Pharma Inks Development Agreement To Produce Ketamine

NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical firm, has announced the signing of a development contract to produce a Ketamine formulation suited for intravenous administration in accordance with current FDA manufacturing rules...

© 2024 India Pharma Outlook. All Rights Reserved.